Drug intelligence / Profile preview

Autologous Induced Pluripotent Stem Cell-derived Dopamine Progenitor Cells

Development stage: Phase 1
Lead developer: iCamuno Biotherapeutics
Modality: iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
Administration: Intracerebral

Overview

Autologous Induced Pluripotent Stem Cell-derived Dopamine Progenitor Cells (ICA07) is a cell therapy product developed using induced pluripotent stem cells (iPSC). The therapy involves generating autologous iPSCs from the patient and differentiating them into dopamine progenitor cells. These cells are then transplanted into the brain via stereotactic intracerebral injection with the aim of replacing lost dopaminergic neurons and improving motor function in patients with Parkinson's disease. The primary mechanism is cell replacement to restore dopaminergic signaling in neurodegenerative conditions such as Parkinson's disease[1][2][5].

Other names: Autologous Induced Pluripotent Stem Cell-derived Dopamine Progenitor CellsAikailiyuan

Beyond the preview

Go deeper on Autologous Induced Pluripotent Stem Cell-derived Dopamine Progenitor Cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autologous Induced Pluripotent Stem Cell-derived Dopamine Progenitor Cells.

Explore the full profile